Takeda Pharmaceutical (NYSE: TAK) executive sells 3,978 ADSs in tax-related trade

Rhea-AI Filing Summary

Takeda Pharmaceutical Co Ltd reports that executive Shannon Elaine Mary, President, Global Supply & Quality, sold 3,978 American Depositary Shares on 2026-08-10 at a weighted average price of $17.10 per ADS. The company notes this was a mandatory sale to cover taxes associated with vesting equity awards. After the transaction, Mary held 63,333 ADSs directly.

Insider Trade Summary

Net Seller: 3,978 shares

Net Sell 1 txn

Insider Shannon Elaine Mary

Role Pres., Global Supply & Quality

Sold 3,978 shs ($68K)

Type	Security	Shares	Price	Value
Sale	American Depositary Shares F1, F2, F3	3,978	$17.10	$68K

Holdings After Transaction: American Depositary Shares — 63,333 shares (Direct)

Footnotes (3)

1. F1. Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person.
2. F2. The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
3. F3. The total in Column 5 represents the amount of American Depositary Shares held by the Reporting Person as of the date of this filing.

Key Figures

Shares sold: 3,978 ADSs Weighted average sale price: $17.10 per ADS Holdings after transaction: 63,333 ADSs +1 more

4 metrics

Shares sold 3,978 ADSs Mandatory sale to cover taxes on 2026-08-10

Weighted average sale price $17.10 per ADS Sale of 3,978 ADSs on 2026-08-10

Holdings after transaction 63,333 ADSs Directly held by Shannon Elaine Mary after sale

Net shares sold 3,978 ADSs Net-sell direction across all reported transactions

Key Terms

American Depositary Shares, weighted average price, mandatory sale to cover taxes

3 terms

American Depositary Shares financial

"The total in Column 5 represents the amount of American Depositary Shares held"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

mandatory sale to cover taxes financial

"Represents a mandatory sale to cover taxes associated with the vesting"

FAQ

What insider transaction did TAK report for Shannon Elaine Mary?

Takeda Pharmaceutical (TAK) reported that Shannon Elaine Mary sold 3,978 American Depositary Shares on 2026-08-10. The sale was described as a mandatory sale to cover taxes related to vesting equity awards.

At what price were the Takeda (TAK) shares sold in this Form 4?

The reported sale of Takeda (TAK) shares occurred at a weighted average price of $17.10 per ADS. The reporting person offers to provide full trade-by-trade pricing details upon request to the issuer, any security holder, or SEC staff.

How many Takeda (TAK) shares does Shannon Elaine Mary hold after the reported sale?

Following the transaction, Shannon Elaine Mary held 63,333 American Depositary Shares of Takeda (TAK). This figure represents her directly held ADS position as of the filing date, after the tax-related sale.

Was the Takeda (TAK) insider sale part of a discretionary trading plan?

The filing indicates the sale was a mandatory transaction to cover taxes on vesting equity awards, not a discretionary open-market sale. The Rule 10b5-1 checkbox was not marked as an affirmative trading plan for this transaction.

What type of security was involved in the Takeda (TAK) Form 4 transaction?

The reported transaction involved American Depositary Shares (ADSs) of Takeda (TAK). These ADSs represent an interest in the company’s equity and are the form in which the executive’s 3,978-share tax sale and 63,333-share holding are reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/12/2026 - 09:43 PM Accepted by SEC EDGAR 08/12/2026 - 09:42 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shannon Elaine Mary

(Last) (First) (Middle)

45-55 HAYDEN AVENUE

(Street)

LEXINGTON MASSACHUSETTS 02421

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Pres., Global Supply & Quality

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
American Depositary Shares	08/10/2026		S(1)		3,978	D	$17.1(2)	63,333(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person.

2. The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. The total in Column 5 represents the amount of American Depositary Shares held by the Reporting Person as of the date of this filing.

	/s/ Samuel Ntonme, by power of attorney, for Elaine M. Shannon	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)